A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators from Baylor College of Medicine, ...

An international research team led by RMIT University have created tiny particles, known as nanodots, made from a metallic compound that can kill cancer cells while leaving healthy cells largely ...

The concept of using the immune system to treat cancer is old, but the ability to do so has dramatically improved.

BRCA1 and BRCA2 genes play a crucial role in repairing damaged DNA. Mutations in BRCA1 and BRCA2 substantially increase the likelihood of breast and ovarian cancer, respectively. This new research ...

A groundbreaking study may change how doctors treat glioblastoma, one of the deadliest brain cancers. Researchers Virginia Commonwealth University have developed a powerful new therapy using an ...

Researchers at UCLA have created an “off-the-shelf" cell-based immunotherapy that can seek out and destroy pancreatic cancer cells, even after the cancer has spread to other organs.

Cancer treatment has come a long way, but many of today's therapies still come with steep costs: not just financial, but physical and emotional too. Chemotherapy and radiotherapy remain vital tools, ...

Cancer kills more than 500,000 Americans each year. But today, thanks to National Institutes of Health (NIH) funding, UC San Francisco researchers are revolutionizing what we thought we knew about how ...

In cancer, the e1F4a enzyme forces cells to make tons of cancerous proteins. A UCSF team found that the breast cancer drug, zotatifin, turns e1F4a, which normally assists in protein production, into a ...

A credit-card-sized chip may soon outsmart cancer. A team led by NYU Tandon School of Engineering’s Weiqiang Chen has developed a miniature device that could reshape how blood cancer treatments are ...

A study shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators examined how molecular dynamics at the immune synapse -- where ...